Mereo BioPharma Strengthens Management Team; Appoints John Lewicki, PhD, as Chief Scientific Officer and Ann Kapoun, PhD, as SVP of Translational Research and Development

    NEXT STORY
    $1.8+ Billion Worldwide Companion Animal Diagnostics Industry to 2025 – Featuring Zoetis, Heska & Virbac Among Others
    PREV STORY
    Medical Practice Income, Inc., a Subsidiary of USA Equities Corp., Announces QHSLab
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Osteoarthritis – Forecast in 12 Major Markets 2016-2026

    Dublin, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

    author_avatar
    NASDAQ Market News

    Loxo Oncology to Announce Fourth Quarter and Year-End 2017 Financial Results

    STAMFORD, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    New data demonstrate the continued clinical benefit of fixed-duration, chemotherapy-free Venclexta/Venclyxto-based treatments in chronic lymphocytic leukaemia

    author_avatar
    NASDAQ Market News